who should not take glp-1 drugs The Science Behind Medications: Facts vs Hype Wait - Maybe You Should
Description
A substudy examining participants with metabolic-associated steatotic liver disease produced results that no pharmacological intervention had previously achieved
The data also suggests that GI AEs appear similar between liraglutide and exenatide twice daily, while the occurrence of GI AEs appears to be less in patients taking exenatide once weekly compared with exenatide twice daily and compared to liraglutide once weekly [Drucker et al
Naltrexone ER/Bupropion ER: A review in obesity management
67 Regarding aging, activating GLP-1R enhances insulin sensitivity and addresses age-associated IR, a critical factor in metabolic disorders such as T2D
doi:10.1016/j.molmet.2018.09.009 75
doi: 10.1038/oby.2011.330
